Skip to content

ANGLE vs Ikonisys

ANGLE logo

ANGLE

The leading experts in cancer cell capture and analysis from liquid biopsies

165 employees · est. 1994 · United Kingdom

VS
Ikonisys logo

Ikonisys

Finding the cells that matter

39 employees · est. 1999 · France

ANGLE is the older company (1994 vs 1999); ANGLE is the larger of the two.

Side-by-Side Comparison

ANGLE Ikonisys
Founded
1994 older 1999
Headquarters
United Kingdom France
Employees
165 larger 39
Industry
Biotechnology, Health Care, Medical Devices Biotechnology, Health Care
Funding Stage
Post-IPO Equity Post-IPO Equity
Total Funding
$29.68M $50.06M
Funding Rounds
3 9
Services
Not tracked yet Fluorescence In Situ Hybridization Technology, Automated Cancer Diagnostics, Rare Cell Detection, Microscope Slide Analysis, Genetic Testing Platform
Target Customers
Not tracked yet Oncology Diagnostic Labs, Pathologists, Healthcare Professionals, Medical Researchers, Biomedical Engineers
Taxonomy
Liquid BiopsyCirculating Tumor CellsMedical Device ManufacturerMicrofluidicsCTC Diagnostic SolutionsFDA Cleared Technology +8 Rare Cell DetectionCancer DiagnosticsCTCLiquid BiopsyMedical TechnologyFluorescence Microscopy +8
Website
angleplc.com ikonisys.com
ANGLE logo

About ANGLE

ANGLE, the leading experts in cancer cell capture and analysis from liquid biopsies, is a world-leading liquid biopsy company specializing in innovative circulating tumor cell (CTC) diagnostic solutions. ANGLE's FDA cleared and patent-protected circulating tumor cell (CTC) harvesting technology, the...

Ikonisys logo

About Ikonisys

is a biotechnology startup based in France that is revolutionizing diagnostic medicine with its focus on early, accurate, and non-invasive disease detection. Its breakthrough fluorescence microscopy platform, Ikoniscope20®, is a robotic, high-throughput system that provides a walk-away automated so...

Also comparing in this category

Comparing more than these two?

Get ANGLE, Ikonisys and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does ANGLE compare?

A PDF of ANGLE and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

ANGLE was founded in 1994, based in United Kingdom, with 165 employees. ANGLE, the leading experts in cancer cell capture and analysis from liquid biopsies, is a world-leading liquid biopsy company specializing in innovative circulating tumor cell (CTC) diagnostic solutio. Ikonisys was founded in 1999, based in France, with 39 employees. is a biotechnology startup based in France that is revolutionizing diagnostic medicine with its focus on early, accurate, and non-invasive disease detection. Its breakthrough fluorescence microscopy p.
ANGLE has raised $29.68M and Ikonisys $50.06M. Latest stage: ANGLE Post-IPO Equity, Ikonisys Post-IPO Equity.
Both work in Biotechnology and Health Care and list liquid biopsy and cancer diagnostics among their focus areas.

Compare ANGLE with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at ANGLE on 14 Sep 2024, and Ikonisys on 7 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout